Read the latest PLC CEO interviews. CEO’s from UK listed PLC’s, Analysts and Fund Managers answering questions about their business.
PetroNeft Resources plc (LON:PTR) Chief Executive Officer David Sturt caught up with DirectorsTalk for an exclusive interview to discuss how the production increase was achieved, what they are hoping to..
Flowtech Fluidpower plc (LON:FLO) is the topic of conversation when Zeus Capital’s Research Director Andy Hanson caught up with DirectorsTalk for an exclusive interview. Q1: Flowtech Fluidpower issued a trading..
Jubilee Metals Group plc (LON:JLP) Chief Executive Officer Leon Coetzer caught up with DirectorsTalk for an exclusive interview to discuss their extraordinary growth, renewed interest from established financial institutions and..
SourceBio International plc (LON:SBI) Executive Chairman Jay LeCoque discusses the company’s trading update for the year ended 31st December 2020. You announced a strong trading update for the year ended..
Autins Group plc (LON:AUTG) Chief Executive Officer Gareth Kaminski-Cook caught up with DirectorsTalk for an exclusive interview to discuss their final results, how they rapidly responded to supply PPE, where..
Norman Broadbent plc (LON:NBB) Chief Executive Officer Mike Brennan caught up with DirectorsTalk for an exclusive interview to discuss their latest trading update, how their strategy played out during the..
Sumo Group plc (LON:SUMO) is the topic of conversation when Zeus Capital’s Technology Analyst Bob Liao caught up with DirectorsTalk for an exclusive interview. Q1: The company have released a..
NQ Minerals plc (AQSE:NQMI) Executive Chairman David Lenigas caught up with DirectorsTalk for an exclusive interview to discuss the start of surface trenching at Beaconsfield, what this means for the..
Volta Finance plc (LON:VTA) is the topic of conversation when Hardman and Co’s Analyst Mark Thomas caught up with DirectorsTalk for an exclusive interview. Q1: Your recent report on Volta..
Cerillion plc (LON:CER) Chief Executive Officer Louis Hall caught up with DirectorsTalk for an exclusive interview to discuss what the company does, key highlights from the latest updates, the new..
Drumz plc (LON:DRUM) Chief Executive Officer Angus Forrest caught up with DirectorsTalk to discuss Acuity’s upgraded STREAM product, the changes made, what opportunities this brings to the company and what..
Premier Miton Investors plc (LON:PMI) Head of Equities and Fund Manager Gervais Williams caught up with DirectorsTalk to discuss US expenditure, inflation, gold mining and cryptocurrencies. Q1: Gervais, with the..
Biome Technologies plc (LON:BIOM) Chief Executive Officer Paul Mines caught up with DirectorsTalk to discuss their video ‘Challenging Materials: Biodegradable Tree Shelters’, the scale of the challenge, the company’s answer..
TT Electronics plc (LON:TTG) Chief Executive Officer Richard Tyson and Chief Financial officer Mark Hoad caught up with DirectorsTalk for an exclusive interview to discuss improved trading performance, cash performance..
Ilika plc (LON:IKA) is the topic of conversation when Baden Hill’s Partner and Clean-Tech Equity Specialist Dr Tom McColm caught up with DirectorsTalk for an exclusive interview. Q1: Ilika’s share..
PetroNeft Resources plc (LON:PTR) Chief Executive Officer David Sturt caught up with DirectorsTalk for an exclusive interview to discuss the potential acquisition of a further 40% of licence 67, more..
Cerillion plc (LON:CER) is the topic of conversation when we caught up with Janardan Menon Equity Research Analyst at Liberum. Q. Cerillion has issued a press release announcing a major..
NQ Minerals plc (AQSE:NQMI) Executive Chairman David Lenigas caught up with DirectorsTalk for an exclusive interview to discuss their year-end operations update, achieving better than expected production rates, a new..
KRM22 plc (LON:KRM) Executive Chairman Keith Todd caught up with DirectorsTalk for an exclusive interview to discuss their latest trading update, deals in the pipeline, the effect of signing two..
Shield Therapeutics plc (LON:STX) is the topic of conversation when Hardman and Co’s Analyst Dr Martin Hall caught up with DirectorsTalk for an exclusive interview. Q1: Shield Therapeutics was one..
